Frog Skin Antimicrobial Peptide 3-13 and Its Analogs Alleviate Atherosclerosis Cholesterol Accumulation in Foam Cells via PPARγ Signaling Pathway
Cells · 2025
DOI: 10.3390/cells14181470 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Xue-Feng Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian 116029, China. Hauptthemen laut MEDLINE: PPAR gamma, Atherosclerosis, Foam Cells, Cholesterol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research Project of Liaoning Provincial Department of Education.
Abstract (Originalsprache)
Atherosclerosis (AS), a major contributor to cardiovascular disease, hypertension, and stroke, is associated with significant morbidity and mortality. Antimicrobial peptides (AMPs) 3-13, W3R6, and chensinin-1b were engineered based on the sequence of chensinin-1, originally isolated from the skin secretion of Rana chensinensis. This study investigated their therapeutic potential in ApoE-/- AS mice and THP-1-derived foam cells, focusing on the regulation of cholesterol metabolism. AMP 3-13 markedly reduced body weight gain, aortic root plaque formation, and plasma cholesterol levels in ApoE-/- mice. Transcriptomic analysis revealed that AMP 3-13 significantly altered gene expression related to cholesterol metabolism and the PPAR signaling pathway. Specifically, AMP 3-13 upregulated PPARγ, ABCA1, and ABCG1, while downregulating CD36 in aortic root plaques. In THP-1-derived foam cells, AMP 3-13 and its analogs activated the PPARγ–ABCA1/ABCG1 axis, enhancing cholesterol efflux. Concurrently, they inhibited CD36 expression by competing with PPARγ for promoter binding, thereby reducing ox-LDL uptake. These findings suggested that AMP 3-13 and its analogs represented promising therapeutic agents for AS through their ability to reduce cholesterol accumulation in foam cell.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Science, Liaoning Provincial Key Laboratory of Biotechnology and Drug Discovery, Liaoning Normal University, Dalian 116029, China.
- School of Basic Medical Sciences, Department of Physiology, Jinzhou Medical University, Jinzhou 121000, China.
ORCID-Profile: Xue-Feng Yang
Förderung
- National Natural Science Foundation of China
- Key Research Project of Liaoning Provincial Department of Education
Zitieren
APA
Yang, X. F., Hao, Z. M., Cui, X. Y., Liu, W. Q., Li, M. M., & Shang, D. J. (2025). Frog Skin Antimicrobial Peptide 3-13 and Its Analogs Alleviate Atherosclerosis Cholesterol Accumulation in Foam Cells via PPARγ Signaling Pathway. Cells. https://doi.org/10.3390/cells14181470
Vancouver
Yang XF, Hao ZM, Cui XY, Liu WQ, Li MM, Shang DJ. Frog Skin Antimicrobial Peptide 3-13 and Its Analogs Alleviate Atherosclerosis Cholesterol Accumulation in Foam Cells via PPARγ Signaling Pathway. Cells. 2025. doi:10.3390/cells14181470
BibTeX
@article{Yang2025,
author = {Yang, Xue-Feng and Hao, Zi-Meng and Cui, Xin-Yu and Liu, Wan-Qi and Li, Meng-Miao and Shang, De-Jing},
title = {Frog Skin Antimicrobial Peptide 3-13 and Its Analogs Alleviate Atherosclerosis Cholesterol Accumulation in Foam Cells via PPARγ Signaling Pathway},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14181470}
}
EUVIMED